Malignant neoplasm of thyroid gland, including Hilmo

C3_THYROID_GLAND_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C73 Hospital discharge: ICD-9 — 193 Hospital discharge: ICD-8 — 193 Cause of death: ICD-10 — C73 Cause of death: ICD-9 — 193 Cause of death: ICD-8 — 193 Cancer registry: Topography ICD-O-3 — C73 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	3107
4. Check minimum number of events None	3107
5. Include endpoints None	3107
6. Filter based on genotype QC (FinnGen only)	3003

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_THYROID_GLAND_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C73
HD_ICD_9	193
HD_ICD_8	193
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C73
COD_ICD_9	193
COD_ICD_8	193
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C73
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of thyroid gland, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3003	2221	782
Unadjusted period prevalence (%)	0.68	0.79	0.36
Median age at first event (years)	52.05	49.64	58.90

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3106: Matched controls
31060

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

EP1AE

NOMESCO Finland

Neck ultrasound examination

47.1

307.7

1465

578

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

307.7

381

BAA60

NOMESCO Finland

Total thyroidectomy

133.0

307.7

1681

273

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

82.0

307.7

221

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

307.7

449

A04AA02

ATC

granisetron; systemic, transdermal

178.7

307.7

169

A11CC03

ATC

alfacalcidol; systemic

15.7

307.7

303

212

106

Kela drug reimbursment

Hypoparathyroidism

77.3

307.7

182

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.4

307.7

1846

6582

4CJ01, ,

NOMESCO Finland

+∞

307.7

316

H02AB02

ATC

dexamethasone; systemic

23.5

307.7

335

159

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

107.4

307.7

201

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

10.6

307.7

512

567

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

+∞

307.7

339

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

3979.8

307.7

364

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

60.2

307.7

229

ZX114

NOMESCO Finland

Intramuscular

49.6

307.7

469

111

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

175.1

307.7

853

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

107.2

307.7

857

110

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

307.7

2383

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

307.7

2024

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

23.3

307.7

338

162

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

307.7

696

104

Kela drug reimbursment

Thyroid insufficiency

55.0

307.7

2171

1258

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

79.4

307.7

1034

194

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

307.7

426

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

363

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

32.4

307.7

751

303

H03AA01

ATC

levothyroxine sodium; systemic

57.8

307.7

2871

5423

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

36.2

307.7

437

140

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

149.9

286.9

143

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

66.1

264.1

145

115

Kela drug reimbursment

Breast cancer

+∞

251.5

238

WF002

NOMESCO Finland

Radical radiotherapy

61.0

251.5

140

D34

ICD-10 Finland

Benign neoplasm of thyroid gland

27.3

244.7

168

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

13.4

244.3

237

191

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

243.0

230

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

+∞

243.0

230

8330/3-C73.9

ICD-O-3

Follicular carcinoma, NOS, of thyroid gland

+∞

236.5

224

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

+∞

236.5

224

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

11.7

236.2

250

231

Z51.88

ICD-10 Finland

Other specified medical care

12.3

221.6

226

197

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

39.8

206.3

126

PJA12

NOMESCO Finland

Sentinel node biopsy

433.5

205.8

204

WX408

NOMESCO Finland

General anesthesy, balanced

3.3

202.1

1094

4406

WX402

NOMESCO Finland

General anaesthesia

3.5

201.1

919

3335

T71

ICPC

Malignant neoplasm thyroid

+∞

198.1

188

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

8.6

195.1

260

327

E83.51

ICD-10 Finland

Hypocalcemia

26.4

183.5

127

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

6.9

175.1

286

452

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

29.1

171.8

115

A11CC02

ATC

dihydrotachysterol; oral

43.5

169.2

101

2506

FHL

Thyroidectomy

301.1

168.6

170

WZC00

NOMESCO Finland

Treatment plan or consultation

2.8

168.1

1295

6235

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.2

166.2

857

3302

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

19.1

164.2

130

XX3DW

NOMESCO Finland

Time consuming IT work

5.6

163.0

334

658

JN4BD

NOMESCO Finland

Extensive body CT

6.0

161.2

302

547

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

159.8

152

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

+∞

159.8

152

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

1470.5

143.9

139

ZXE10

NOMESCO Finland

More than one and less than three hours

2.6

143.8

1361

7136

WF049

NOMESCO Finland

Radiotherapy of metastasis

486.1

141.5

140

HAB40

NOMESCO Finland

Wedge excision of mammary gland

19.1

140.7

111

8341/3-C73.9

ICD-O-3

Papillary microcarcinoma of thyroid gland

+∞

138.6

132

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

133.3

127

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

25.2

132.3

JN6AD

NOMESCO Finland

CT of torso and neck

22.8

129.9

A12AA04

ATC

calcium carbonate; oral

11.2

129.3

138

128

L02BG04

ATC

letrozole; oral

8.9

124.9

158

185

A03FA01

ATC

metoclopramide; systemic, rectal

3.0

123.7

649

2483

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

46.0

122.2

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

7.2

121.8

185

269

C61

ICD-10 Finland

Malignant neoplasm of prostate

1225.2

121.7

118

HA1AA

NOMESCO Finland

X-ray mammography

5.5

120.9

246

479

ZXE20

NOMESCO Finland

More than three and less than five hours

3.3

120.1

526

1808

L03AA02

ATC

filgrastim; parenteral

66.4

118.3

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

114.3

109

L03AA13

ATC

pegfilgrastim; parenteral

387.9

113.2

113

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

112.2

107

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.7

111.9

219

411

C739, ,

ICD-10 Finland

+∞

111.1

106

8340/3-C73.9

ICD-O-3

Papillary carcinoma, follicular variant of thyroid gland

+∞

111.1

106

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

107.9

103

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

56.5

107.9

L02BA01

ATC

tamoxifen; oral

190.0

106.1

110

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1063.9

106.0

103

Z51.5

ICD-10 Finland

Palliative care

6.1

104.8

187

321

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.0

102.9

317

860

HAC20

NOMESCO Finland

Total mastectomy

159.8

102.9

108

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

102.7

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

100.6

JN4AD

NOMESCO Finland

Body CT examination

4.5

100.5

263

631

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.9

98.6

226

487

WF003

NOMESCO Finland

Adjuvant radiotherapy

492.9

97.0

GD6AD

NOMESCO Finland

CT of chest and neck

40.1

96.8

WZC30

NOMESCO Finland

Teaching

2.9

95.3

517

1993

2505

FHL

Bilateral resection (also used if total removal has been performed on the other side)

15.9

95.1

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

935.9

93.4

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

8.1

92.2

126

162

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

92.1

TPH07

NOMESCO Finland

Cathetrisation of artery

3.3

90.3

386

1296

A04AA01

ATC

ondansetron; systemic, rectal

5.0

89.1

199

419

NK6AN

NOMESCO Finland

Total body bone isotope imaging

32.9

85.5

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

34.3

85.0

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

178.9

83.6

C50.99

ICD-10 Finland

Breast, unspecified

819.5

81.8

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

819.5

81.8

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

100.6

80.3

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

22.7

79.3

E03.89

ICD-10 Finland

Other specified hypothyroidism

3.9

78.7

242

653

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

78.0

1284

7956

PJD91

NOMESCO Finland

Excision of lymph nodes in neck, 1 to 2 areas in total

392.0

77.2

GD1AD

NOMESCO Finland

Thorax CT examination

4.1

76.7

224

582

T86

ICPC

Hypothyroidism/myxoedema

3.7

75.8

256

737

A04AA55

ATC

palonosetron, combinations; systemic

+∞

75.3

C73.94

ICD-10 Finland

Medullary thyroid carcinoma (thyroid)

+∞

73.2

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

+∞

73.2

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

724.9

72.4

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

+∞

72.2

WX704

NOMESCO Finland

Intubation

3.1

71.9

329

1144

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

10.2

71.9

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

26.2

70.7

WW200

NOMESCO Finland

Immunization

5.3

70.6

146

287

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

70.1

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

10.5

67.8

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

10.2

65.6

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

23.8

65.5

JN4CD

NOMESCO Finland

Very extensive body CT

7.6

64.1

125

116

Kela drug reimbursment

Prostate cancer

+∞

63.8

WF004

NOMESCO Finland

Palliative radiotherapy

630.7

63.0

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

61.7

L01BC06

ATC

capecitabine; oral

+∞

61.7

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

6.9

61.6

143

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.0

60.6

181

477

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

8.5

60.1

JN5SN, ,

NOMESCO Finland

+∞

58.5

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

57.5

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

55.9

1343

9149

EP1AE, ,

SPAT

5.2

55.3

115

227

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.0

54.6

160

416

ZXA10

NOMESCO Finland

Bilateral

2.1

54.5

645

3467

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

7.3

53.9

110

PJA10

NOMESCO Finland

Exploration of lymph nodes

12.9

53.8

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

53.3

A12AA06

ATC

calcium lactate gluconate; oral

86.0

53.0

C50

ICD-10 Finland

Malignant neoplasm of breast

516.4

51.6

C73.93

ICD-10 Finland

Anaplastic thyroid carcinoma (thyroid)

+∞

50.1

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

50.1

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.5

49.5

124

286

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

49.1

ZXA05

NOMESCO Finland

Left side

1.9

48.4

761

4496

ZX090

NOMESCO Finland

Other technic of radiotherapy

78.6

48.1

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

474.9

47.4

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

+∞

47.0

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

47.0

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

47.0

DQE10

NOMESCO Finland

Injection of foreign material into vocal cord

15.4

46.9

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

4.3

46.6

121

287

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

8.0

46.5

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

17.5

46.3

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

45.9

ZX070

NOMESCO Finland

Intensity modified radiotherapy

124.4

45.9

BAA20

NOMESCO Finland

Unilateral partial excision of thyroid gland

14.3

45.1

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.9

44.1

BAA99

NOMESCO Finland

Other operation on thyroid gland

155.6

43.9

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

43.8

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

43.4

506

2684

A79

ICPC

Malignancy NOS

413.0

41.2

Z31.5

ICD-10 Finland

Genetic counselling

3.1

41.0

178

597

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

40.8

624

3630

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

40.7

8290/3-C73.9

ICD-O-3

Oxyphilic adenocarcinoma of thyroid gland

+∞

40.7

N02AA05

ATC

oxycodone; systemic

2.1

39.8

416

2115

ZSB00

NOMESCO Finland

Procedure related to previous procedure classified in chapter B

53.0

39.6

ZX080

NOMESCO Finland

Image guided radiotherapy

202.5

38.9

L02BG03

ATC

anastrozole; oral

87.3

38.9

198

Kela drug reimbursment

Sorafenib

+∞

38.6

B01AB05

ATC

enoxaparin; parenteral

1.7

38.4

875

5724

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

5.0

38.3

170

N02BE01

ATC

paracetamol; systemic, rectal

2.1

37.9

2754

24477

X76

ICPC

Malignant neoplasm breast female

135.0

37.8

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

62.3

37.2

2504

FHL

Unilateral resection or enucleation

6.9

36.9

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

49.5

36.7

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

36.5

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

36.5

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

36.5

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

+∞

36.5

BA1AQ

NOMESCO Finland

Thyroid SPECT with low dose CT

361.4

36.0

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

361.4

36.0

JN5AN

NOMESCO Finland

Total body isotope imaging

+∞

35.5

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

35.5

8345/3-C73.9

ICD-O-3

Medullary thyroid carcinoma of thyroid gland

+∞

35.5

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

35.5

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

10.1

35.4

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

3.2

35.3

141

450

WX725

NOMESCO Finland

Noninvasive ventilation

2.7

34.8

191

728

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

47.3

34.7

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

5.5

34.6

124

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

51.9

34.5

ZXE00

NOMESCO Finland

One hour or less

1.6

34.3

1146

8233

Y77

ICPC

Malignant neoplasm prostate

340.9

34.0

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

11.8

33.4

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

33.4

8510/3-C73.9

ICD-O-3

Medullary carcinoma, NOS, of thyroid gland

+∞

33.4

ZXA00

NOMESCO Finland

Right side

1.7

33.3

773

5051

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.7

33.1

181

689

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

330.6

32.9

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

75.0

32.9

A04AD12

ATC

aprepitant; systemic

118.0

32.7

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

8.6

32.3

B01AB10

ATC

tinzaparin; parenteral

2.3

32.1

254

1150

L02BG06

ATC

exemestane; oral

320.3

31.9

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

88.5

31.8

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

31.3

H03BB01

ATC

carbimazole; oral

2.7

30.9

176

684

ZX112

NOMESCO Finland

Subcutaneous

6.6

30.6

E03

ICD-10 Finland

Other hypothyroidism

2.3

30.5

245

1116

3019

Kela drug reimbursment

Lenvatinib

+∞

30.3

E8901, C7391,

ICD-10 Finland

+∞

30.3

TQW20

NOMESCO Finland

Tatoe

68.6

29.9

L02AE02

ATC

leuprorelin; implant, parenteral

5.4

29.7

112

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.1

29.6

209

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

29.2

1508

Kela drug reimbursment

Lenvatinib

+∞

29.2

323

Kela drug reimbursment

Sorafenib

+∞

29.2

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.5

28.9

191

797

PJD99

NOMESCO Finland

Excision of other lymph nodes

294.7

28.8

L03AA14

ATC

lipegfilgrastim; parenteral

294.7

28.8

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

49.1

28.4

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

3.9

28.1

217

S18

ICPC

Laceration/cut

1.5

27.9

1268

9650

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

6.0

27.8

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.6

27.7

163

643

KCD02

NOMESCO Finland

Transurethral resection of bladder

11.2

27.6

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.4

27.3

102

8000/3-C73.9

ICD-O-3

Neoplasm, malignant of thyroid gland

+∞

27.1

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

27.1

XX1MN

NOMESCO Finland

Isotope examination with measurement

+∞

27.1

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

26.7

27.1

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

75.8

26.8

XX9XW, ,

NOMESCO Finland

7.5

26.7

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

10.1

26.5

WW500

NOMESCO Finland

Blood transfusion

3.9

26.5

208

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.5

26.4

170

701

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

52.1

26.2

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

26.1

704

4739

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

26.1

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

94.2

25.7

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

22.7

25.2

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

25.0

8020/3-C73.9

ICD-O-3

Carcinoma, undifferentiated, NOS, of thyroid gland

+∞

25.0

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

25.0

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

4.3

24.9

155

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.1

24.8

259

1307

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

70.5

24.8

A06AH03

ATC

naloxegol; oral

8.7

24.5

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

24.0

1930X

ICD-9 Finland

Malignant neoplasm of thyroid gland[NEOPLASMA MALIGNUM THYREOIDEAE EI HISTOL VAHV]

+∞

24.0

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

24.0

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

22.9

23.9

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.2

23.8

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

241.8

23.7

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

2.9

23.3

114

409

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

23.1

132

513

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

22.9

L02BB03

ATC

bicalutamide; oral

+∞

22.9

Z51.0

ICD-10 Finland

Radiotherapy session

84.1

22.7

JDB10

NOMESCO Finland

Percutaneous gastrostomy

7.2

22.5

SPAT1153

SPAT

Removal of sutures

1.5

22.2

854

6200

ZX050

NOMESCO Finland

Stereotactic radiotherapy

52.4

22.1

L01XE05

ATC

[U] sorafenib

+∞

21.9

1930B

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA FOLLICULARE THYREOIDEAE]

+∞

21.9

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

21.9

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

21.9

BA2AT

NOMESCO Finland

Biopsy of thyroid with ultrasound quidance

29.3

21.8

R49.08

ICD-10 Finland

Other specified dysphonia

3.1

21.8

314

BWD00

NOMESCO Finland

Reoperation for deep haemorrhage in endocrine surgery

38.9

21.7

WA039

NOMESCO Finland

Radiotherapy with free isotopes

221.5

21.6

R13

ICD-10 Finland

Dysphagia

2.1

21.5

219

1095

J01DB01

ATC

cefalexin; oral

1.5

21.3

2448

21926

24199

ICD-8 Finland

Non-toxic nodular goitre, Unspecified

4.8

21.3

102

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

7.3

21.2

R4110

NOMESCO Finland

Physiotherapy

1.5

21.0

714

5039

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

8.1

20.9

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

20.9

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

20.9

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

20.9

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

211.4

20.6

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

211.4

20.6

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

3.7

20.6

174

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

30.2

20.5

E20.8

ICD-10 Finland

Other hypoparathyroidism

41.9

20.4

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

6.1

20.3

R49.01

ICD-10 Finland

Functional dysphonia

2.6

20.3

122

487

E21.0

ICD-10 Finland

Primary hyperparathyroidism

3.3

20.2

234

Z50.5

ICD-10 Finland

Speech therapy

4.3

20.2

123

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

48.3

20.2

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

48.3

20.2

ZZR00

NOMESCO Finland

Flap of skin

6.8

20.0

EP1BG

NOMESCO Finland

MRI examination of soft tissue of neck with high intesity magnet

7.6

20.0

BAA30

NOMESCO Finland

Excision of thyroid isthmus

23.5

19.9

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

19.8

244

1304

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

19.8

424

2674

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

19.8

L01EX08

ATC

lenvatinib; oral

+∞

19.8

1AB01, ,

NOMESCO Finland

+∞

19.8

BA2MN

NOMESCO Finland

Thyroid radiation dose measurement during isotope therapy

+∞

19.8

ZX120

NOMESCO Finland

Intravenous

2.1

19.7

195

965

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

105.7

19.6

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

19.5

175

833

R4130

NOMESCO Finland

Speech therapy

3.0

19.4

287

WX720

NOMESCO Finland

Own respiration

2.3

19.2

152

687

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.0

19.2

217

1126

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

19.2

220

1148

XKD00

NOMESCO Finland

Uroflowmetry

1.9

19.1

272

1525

E20.9

ICD-10 Finland

Hypoparathyroidism, unspecified

22.7

19.0

ZXC96

NOMESCO Finland

Robot assisted procedure

5.3

18.9

XW000

NOMESCO Finland

Bone marrow biopsy

2.9

18.9

297

UJC01

NOMESCO Finland

Scopy of lower throat

5.5

18.8

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

18.8

8010/3-C73.9

ICD-O-3

Carcinoma, NOS, of thyroid gland

+∞

18.8

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

18.8

3025

Kela drug reimbursment

Calcium carbonate

8.1

18.8

RL210, ,

NOMESCO Finland

6.8

18.7

C90.0

ICD-10 Finland

Multiple myeloma

191.1

18.5

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

191.1

18.5

T85

ICPC

Hyperthyroidism/thyrotoxicosis

5.4

18.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

18.5

316

1872

WX400

NOMESCO Finland

Inhalation anesthesy

2.4

18.4

130

560

E83.50

ICD-10 Finland

Hypercalcemia

4.3

18.3

111

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

18.3

2047

17899

S04

ICPC

Lump/swelling localized

1.8

18.1

295

1724

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.7

17.8

149

EP1DM

NOMESCO Finland

Very extensive MRI examination of soft tissue of neck with 3 Tesla magnet

67.0

17.7

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

67.0

17.7

XX1XN

NOMESCO Finland

Other isotope examination

+∞

17.7

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

17.7

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

17.7

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

17.7

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

17.7

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

20.2

17.7

Z3226

NOMESCO Finland

Physiotherapist

1.6

17.7

484

3241

128

Kela drug reimbursment

Cancers of female genital organs

181.0

17.5

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

13.2

17.4

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.2

17.4

210

R50.9

ICD-10 Finland

Fever, unspecified

1.7

17.1

350

2178

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

12.6

17.1

4701

FHL

Neck lymph node removal

31.6

17.0

GBB00

NOMESCO Finland

Tracheostomy

5.1

16.9

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

16.7

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

16.7

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

16.7

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

16.7

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

16.7

L01CA04

ATC

vinorelbine; systemic

+∞

16.7

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

35.2

16.7

E04.8

ICD-10 Finland

Other specified nontoxic goitre

6.5

16.6

BA1AE, ,

SPAT

3.8

16.5

129

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

170.9

16.5

XX2RW, ,

NOMESCO Finland

5.7

16.3

E07.9

ICD-10 Finland

Disorder of thyroid, unspecified

6.3

16.3

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

16.0

197

1054

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.8

15.8

299

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

15.6

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

15.6

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

15.6

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

15.6

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

15.6

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

15.6

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

15.6

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

15.6

EP1CM

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with 3 Tesla magnet

26.4

15.6

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

85.5

15.6

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

85.5

15.6

ZZF00

NOMESCO Finland

Graft of adipose tissue

6.7

15.3

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.3

15.2

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

15.1

276

1664

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

4.2

15.1

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

45.2

15.1

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.2

14.9

183

B01AB04

ATC

dalteparin; parenteral

2.1

14.6

132

631

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

14.6

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

14.6

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

14.6

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

14.6

H01CB03

ATC

lanreotide; parenteral

150.7

14.5

Z2221

NOMESCO Finland

Medical doctor

1.4

14.4

729

5511

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

2.0

14.4

156

799

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.2

14.3

183

UDQ02

NOMESCO Finland

Direct laryngoscopy

4.4

14.3

2419X

ICD-9 Finland

Non-toxic nodular goitre, Unspecified non-toxic nodular goitre

6.2

14.2

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

2.1

14.2

128

612

UJF32

NOMESCO Finland

Coloscopy

1.4

14.1

660

4914

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

42.7

14.1

KAC10

NOMESCO Finland

Total nephrectomy with capsule

30.2

13.9

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

53.6

13.8

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

53.6

13.8

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

20.1

13.8

D25.1

ICD-10 Finland

Intramural leiomyoma of uterus

1.8

13.8

194

1084

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

1.7

13.7

278

1723

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

13.7

232

1370

XX1AD

NOMESCO Finland

Other CT-examination

75.5

13.6

T73

ICPC

Neoplasm endocrine other/unspecified

75.5

13.6

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

13.5

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

13.5

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

13.5

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

13.5

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

13.5

L01XE29

ATC

[U] lenvatinib

+∞

13.5

1CD02, ,

NOMESCO Finland

+∞

13.5

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

13.5

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

13.5

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

13.5

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

13.5

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

3.6

13.5

124

2410A

ICD-9 Finland

Non-toxic nodular goitre, Non-toxic uninodular goitre

10.9

13.5

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.6

13.3

T81

ICPC

Goitre

5.8

13.2

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.6

13.1

117

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

15.1

13.1

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.1

13.0

178

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.9

12.9

205

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.1

12.9

168

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

12.8

208

1212

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

50.2

12.8

A02BC02

ATC

pantoprazole; systemic

1.3

12.8

1902

16869

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

11.6

12.8

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

3.4

12.7

129

ELB40

NOMESCO Finland

Partial parotidectomy

3.8

12.7

101

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

2.0

12.7

132

666

Z3231

NOMESCO Finland

Registered nurse

1.4

12.6

658

4985

2260A

ICD-9 Finland

Benign neoplasm of thyroid gland[NEOPLASMA BENIGNUM GLANDULAE THYREOIDEAE]

12.3

12.6

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

70.2

12.6

M05BX04

ATC

denosumab; parenteral

2.0

12.6

142

738

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

12.5

L02BX02

ATC

degarelix; parenteral

+∞

12.5

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

12.5

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

+∞

12.5

153

Kela drug reimbursment

Lenalidomid

+∞

12.5

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

12.5

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

12.5

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

+∞

12.5

329

Kela drug reimbursment

Lenalidomide

+∞

12.5

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

12.5

ZZR10

NOMESCO Finland

Flap of skin and muscle

17.4

12.5

H02AB09

ATC

hydrocortisone; systemic

2.7

12.5

254

FM1FN

NOMESCO Finland

Heart function isotope examination

130.5

12.4

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

15.9

12.1

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

3.2

12.0

144

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

5.3

12.0

N63

ICD-10 Finland

Unspecified lump in breast

1.9

11.9

163

902

ZXB10

NOMESCO Finland

Medial

5.7

11.9

ENB50

NOMESCO Finland

Excision of cyst or fistula of thyroglossic duct

13.4

11.9

GAB20

NOMESCO Finland

Median sternotomy

46.8

11.9

J01MA12

ATC

levofloxacin; systemic

1.5

11.9

420

2958

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

11.9

357

2431

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.9

11.8

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

10.5

11.7

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.5

11.6

275

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

11.6

190

1111

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

11.5

471

3409

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

11.5

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

11.5

L02BA03

ATC

fulvestrant; parenteral

+∞

11.5

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

11.5

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

11.5

L04AX04

ATC

lenalidomide; oral

+∞

11.5

L01EX02

ATC

sorafenib; oral

+∞

11.5

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

11.5

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

11.5

D44.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified

120.5

11.4

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

120.5

11.4

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.6

11.4

266

BAA50

NOMESCO Finland

Lobectomy and resection of contralateral lobe of thyroid gland

15.1

11.3

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

35.1

11.3

D70.82

ICD-10 Finland

Drug-induced neutropenia

8.9

11.2

HAE99

NOMESCO Finland

Other reconstruction of breast

12.7

11.1

EP1AT

NOMESCO Finland

Punction of soft tissue of neck with ultrasound guidance

20.1

11.1

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

11.1

312

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

11.0

796

6335

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.5

11.0

107

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

4.0

10.9

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.1

10.9

148

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.2

10.8

133

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

3.3

10.8

118

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

9.6

10.7

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

10.6

175

1025

UDC00

NOMESCO Finland

Ear microscopy

1.7

10.6

191

1147

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

60.2

10.6

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.1

10.6

140

J37.0

ICD-10 Finland

Chronic laryngitis

2.1

10.6

468

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

14.2

10.5

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

14.2

10.5

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

110.4

10.4

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

10.4

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

10.4

197

Kela drug reimbursment

Sunitinib

+∞

10.4

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

10.4

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

10.4

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

10.4

8335/3-C73.9

ICD-O-3

Follicular carcinoma, minimally invasive of thyroid gland

+∞

10.4

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

+∞

10.4

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

10.4

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

10.4

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

10.4

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

10.4

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

10.4

L02AE03

ATC

goserelin; implant

4.3

10.3

E89.0

ICD-10 Finland

Postprocedural hypothyroidism

13.1

10.1

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

10.0

1113

9378

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

3.5

10.0

BBA20

NOMESCO Finland

Exploration of parathyroid gland

7.6

9.9

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

3.1

9.9

125

S77

ICPC

Malignant neoplasm of skin

16.7

9.9

XQ846

NOMESCO Finland

Digital dermatoscopy and registration of nevi

26.1

9.8

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

26.1

9.8

DQE20

NOMESCO Finland

Implantation of foreign material in vocal chord

26.1

9.8

2397A

ICD-9 Finland

Neoplasm of unspecified nature, Endocrine glands and other parts of nervous system

20.1

9.8

J01MA02

ATC

ciprofloxacin; systemic

1.3

9.8

968

8030

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

8.7

9.8

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.0

9.8

147

R07.0

ICD-10 Finland

Pain in throat

1.7

9.7

185

1129

UGB02

NOMESCO Finland

Tracheoscopy

13.4

9.7

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

9.6

734

5871

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

9.6

192

1187

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

9.5

776

6264

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

9.4

107

558

E34.0

ICD-10 Finland

Carcinoid syndrome

100.3

9.4

23914

ICD-8 Finland

Neoplasm of unspecified nature of other and unspecified organs, Glandulae thyreoideae

100.3

9.4

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.7

9.4

184

L01AX03

ATC

temozolomide; systemic

+∞

9.4

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

9.4

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

9.4

189

Kela drug reimbursment

Imatinib

+∞

9.4

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

9.4

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

9.4

L01XE01

ATC

[U] imatinib

+∞

9.4

L02BB04

ATC

enzalutamide; oral

+∞

9.4

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

+∞

9.4

L01CB01

ATC

etoposide; systemic

+∞

9.4

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

9.4

C75

ICD-10 Finland

Malignant neoplasm of other endocrine glands and related structures

+∞

9.4

D09.3

ICD-10 Finland

Carcinoma in situ: Thyroid and other endocrine glands

+∞

9.4

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

9.4

Q18.0

ICD-10 Finland

Sinus, fistula and cyst of branchial cleft

5.2

9.4

2411A

ICD-9 Finland

Non-toxic nodular goitre, Non-toxic multinodular goitre

4.9

9.3

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

9.3

1410

12315

HA1HA

NOMESCO Finland

Tomosynthesis mammography

13.7

9.2

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

9.0

212

1364

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

2.8

9.0

165

WZC15, ,

NOMESCO Finland

15.6

9.0

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

18.6

8.9

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

8.9

514

E26.0

ICD-10 Finland

Primary hyperaldosteronism

4.1

8.7

UDQ22

NOMESCO Finland

Microlaryngoscopy

4.1

8.7

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

50.1

8.7

E04

ICD-10 Finland

Other nontoxic goitre

6.6

8.6

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.8

8.6

152

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.3

8.6

259

R21

ICPC

Throat symptom/complaint

1.4

8.6

536

4156

HAD99

NOMESCO Finland

Other plastic operation on breast

8.2

8.6

A02BC05

ATC

esomeprazole; systemic

1.3

8.6

1124

9621

GB1AA

NOMESCO Finland

Tracheal X-ray examination

16.3

8.5

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

27.6

8.5

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

27.6

8.5

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

27.6

8.5

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

2.3

8.5

280

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.5

8.5

200

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.5

8.5

206

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

20.1

8.5

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

20.1

8.5

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

90.3

8.4

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

90.3

8.4

L91.0

ICD-10 Finland

Hypertrophic scar

3.0

8.3

122

9680/3-C73.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of thyroid gland

+∞

8.3

192

Kela drug reimbursment

Fulvestrant

+∞

8.3

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

8.3

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

8.3

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

8.3

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

8.3

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

+∞

8.3

19300, ,

ICD-8 Finland

+∞

8.3

L01EA01

ATC

imatinib; oral

+∞

8.3

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

8.3

2374A

ICD-9 Finland

Neoplasm of uncertain behaviour of endocrine glands and nervous system, Other and unspecified endocrine glands

+∞

8.3

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

8.3

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

8.3

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

8.3

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

8.3

C74.9

ICD-10 Finland

Malignant neoplasm: Adrenal gland, unspecified

+∞

8.3

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

8.3

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

8.3

394

Kela drug reimbursment

Palbociclib

+∞

8.3

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

8.3

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

3.6

8.3

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

14.5

8.2

R04.2

ICD-10 Finland

Haemoptysis

2.1

8.2

370

UJC12

NOMESCO Finland

Flexible oesophagoscopy

3.9

8.1

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.7

8.1

152

J01FA10

ATC

azithromycin; systemic

1.2

8.0

1622

14538

R4190

NOMESCO Finland

Nutritional therapy

2.1

8.0

346

2509

FHL

Other measure in this category

22.1

8.0

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

7.2

7.9

WX734

NOMESCO Finland

JET-ventilation

13.0

7.9

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

7.9

322

XJH00

NOMESCO Finland

Transanal ultrasonography

2.0

7.8

425

K11.2

ICD-10 Finland

Sialoadenitis

1.9

7.8

481

WX892

NOMESCO Finland

Monitored bed care

1.6

7.8

161

1006

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

7.7

2666

25394

P01AB01

ATC

metronidazole; oral, rectal

1.2

7.7

1113

9599

LCB25

NOMESCO Finland

Hysteroscopic excision of lesion

1.7

7.7

139

837

E20

ICD-10 Finland

Hypoparathyroidism

45.1

7.7

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

45.1

7.7

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

15.0

7.7

BA3AT, ,

SPAT

15.0

7.7

EL4AT

NOMESCO Finland

Salivary gland cytology with ultrasound guidance

7.4

7.7

D30.0

ICD-10 Finland

Benign neoplasm: Kidney

3.3

7.6

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

7.6

164

1035

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

10.0

7.5

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.2

7.5

256

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.4

7.5

R06.0

ICD-10 Finland

Dyspnoea

1.3

7.5

675

5499

-1, ,

ICD-10 Finland

1.8

7.5

114

655

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

7.5

975

8309

UKC02

NOMESCO Finland

Cystoscopy

1.4

7.5

294

2110

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

80.3

7.4

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

80.3

7.4

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

2.2

7.4

277

T72

ICPC

Benign neoplasm thyroid

6.5

7.4

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

7.4

322

2353

DWD00

NOMESCO Finland

Reoperation for superficial heamorrhage in surgery of ear, nose and larynx

13.4

7.4

Q18.8

ICD-10 Finland

Other specified congenital malformations of face and neck

8.4

7.3

WX002

NOMESCO Finland

Sedation and analgesia

1.3

7.3

467

3630

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

7.3

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

7.3

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

7.3

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

7.3

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

7.3

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

7.3

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

7.3

3012

Kela drug reimbursment

Cabozantinib

+∞

7.3

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

7.3

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

7.3

YX9AW, ,

NOMESCO Finland

+∞

7.3

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

7.3

TKE10

NOMESCO Finland

Puncture of prostate

+∞

7.3

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

7.3

C76.0

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Head, face and neck

+∞

7.3

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

7.3

180

Kela drug reimbursment

Interferon alfa

+∞

7.3

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

7.3

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

7.3

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

7.3

8344/3-C73.9

ICD-O-3

Papillary carcinoma, columnar cell of thyroid gland

+∞

7.3

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

+∞

7.3

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

7.3

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

7.3

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

7.3

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

+∞

7.3

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

+∞

7.3

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

7.3

1930D

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA MEDULLARE THYREOIDEAE]

+∞

7.3

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

7.3

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

7.3

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

7.3

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

7.3

BWA00

NOMESCO Finland

Repair of wound dehiscence in endocrine surgery

+∞

7.3

322

Kela drug reimbursment

Sunitinib

+∞

7.3

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

7.3

1501

Kela drug reimbursment

Palbociclib

+∞

7.3

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

7.3

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

6.8

7.3

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

9.4

7.3

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.8

7.3

121

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.8

7.2

R01AD09

ATC

mometasone; nasal

1.2

7.2

1271

11184

OAA41

NOMESCO Finland

Health check based on individual needs

30.1

7.1

GEB30

NOMESCO Finland

Mediastinotomy and excision of lesion

20.1

7.1

H01CB02

ATC

octreotide; parenteral

20.1

7.1

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

7.1

295

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.8

7.1

128

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.8

7.1

117

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

7.1

230

1591

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

4.1

7.1

E05.4

ICD-10 Finland

Thyrotoxicosis factitia

12.0

7.1

R49.03

ICD-10 Finland

Atrophic dysphonia

2.9

7.0

107

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

3.5

7.0

C07AA05

ATC

propranolol; systemic

1.3

6.9

548

4388

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

6.9

685

5644

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

5.8

6.9

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

6.9

1576

14216

A01AB09

ATC

miconazole; local oral

1.5

6.9

212

1451

J38.3

ICD-10 Finland

Other diseases of vocal cords

2.8

6.8

120

Z43.0

ICD-10 Finland

Attention to tracheostomy

10.9

6.8

C08CA01

ATC

amlodipine; oral

1.2

6.8

952

8164

L02AE04

ATC

triptorelin; parenteral

40.1

6.8

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

40.1

6.8

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

40.1

6.8

HAD00

NOMESCO Finland

Augmentation mammoplasty

40.1

6.8

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

5.7

6.7

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

16.7

6.7

EWE00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of teeth, jaws, mouth and pharynx

16.7

6.7

KED22

NOMESCO Finland

Transurethral resection of prostate

1.9

6.7

384

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.6

6.7

150

M05BA02

ATC

clodronic acid; systemic

22.6

6.7

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.0

6.6

358

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

6.6

279

2027

N05CF01

ATC

zopiclone; oral

1.3

6.6

797

6719

R49.09

ICD-10 Finland

Unspecified dysphonia

2.6

6.5

134

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.5

6.5

207

1425

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

6.5

445

321

Kela drug reimbursment

Paricalcitol and cinacalcet

3.8

6.5

RP210, ,

NOMESCO Finland

10.0

6.5

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

6.8

6.5

R31

ICD-10 Finland

Unspecified haematuria

1.5

6.5

174

1158

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.7

6.5

116

700

C75.0

ICD-10 Finland

Malignant neoplasm: Parathyroid gland

70.0

6.4

D77

ICPC

Malignant digestive neopl other/NOS

70.0

6.4

1XC03, ,

NOMESCO Finland

70.0

6.4

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

70.0

6.4

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

70.0

6.4

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

70.0

6.4

WW300

NOMESCO Finland

Transfer of autologic stem cells

70.0

6.4

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

7.4

6.4

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

7.4

6.4

HA1SA

NOMESCO Finland

Expansion mammography

14.3

6.4

D75

ICPC

Malignant neoplasm colon/rectum

14.3

6.4

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.6

6.4

136

N02AX02

ATC

tramadol; systemic, rectal

1.2

6.4

1069

9326

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

6.3

320

2397

DHB00

NOMESCO Finland

Excision of lesion of external nose

6.5

6.3

S21

ICPC

Skin texture symptom/complaint

1.4

6.3

326

2450

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.3

6.3

185

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.7

6.3

111

667

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

18.0

6.3

2502

FHL

Thyroid exploration and possible biopsy

18.0

6.3

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

18.0

6.3

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1.9

6.3

430

C64.80

ICD-10 Finland

Wilms tumour

+∞

6.3

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

6.3

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

6.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

6.3

DQB60

NOMESCO Finland

Aryotenoidectomy

+∞

6.3

8520/3-C50.8

ICD-O-3

Lobular carcinoma, NOS, of overlapping lesion of breast

+∞

6.3

1930A, ,

ICD-10 Finland

+∞

6.3

WE100

NOMESCO Finland

Profylactic cytostatic therapy

+∞

6.3

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

6.3

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

6.3

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

+∞

6.3

4707

FHL

Dissection Colli radicalis

+∞

6.3

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

6.3

8021/3-C73.9

ICD-O-3

Carcinoma, anaplastic, NOS, of thyroid gland

+∞

6.3

YNB10

NOMESCO Finland

Collection of stem cells for transplant

+∞

6.3

JJB71

NOMESCO Finland

Laparoscopic resection of liver

+∞

6.3

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

6.3

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

+∞

6.3

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

6.3

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

6.3

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

6.3

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

6.3

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

6.3

HAC25

NOMESCO Finland

Radical mastectomy

+∞

6.3

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

6.3

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

6.3

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

6.3

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

6.3

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

6.3

C73, C75,

ICD-10 Finland

+∞

6.3

L01EX07

ATC

cabozantinib; oral

+∞

6.3

L01EX01

ATC

sunitinib; oral

+∞

6.3

C75.9

ICD-10 Finland

Malignant neoplasm: Endocrine gland, unspecified

+∞

6.3

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

6.3

L01EF01

ATC

palbociclib; oral

+∞

6.3

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

26.7

6.2

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

6.2

231

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.4

6.2

174

TQW40, ,

SPAT

1.5

6.1

165

1099

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

7.7

6.1

205

Kela drug reimbursment

Chronic hypertension

1.3

6.1

598

4916

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

2.3

6.1

195

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.8

6.0

105

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

2.9

6.0

TPX15

NOMESCO Finland

Removal of vascular injection port

10.0

6.0

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

6.0

125

784

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

6.0

184

1259

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

5.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

2054

122

495.13

307.65

7.7

1.1

56.42

131.00

u/ml

0.68

773

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2454

11549

6.36

307.65

12.0

5.4

1.20

1.22

mmol/l

37.23

2100

9799

(3018418) pH of Serum or Plasma

1798

6774

4.93

307.65

8.2

3.2

7.40

1.04

385

1132

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2261

10385

5.33

307.65

9.8

5.0

1.20

1.22

mmol/l

29.63

2179

9265

(4035726) Immunohistochemistry procedure

666

693

11.96

307.65

1.5

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

868

1885

6.00

307.65

3.2

3.5

49.44

85.37

ng/l

43.55

784

1613

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

744

349

27.72

307.65

1.5

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1804

1682

24.20

307.65

7.1

3.0

4.51

4.50

pmol/l

0.19

1755

1481

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

2076

2719.83

307.65

7.4

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1655

7603

3.52

258.86

4.1

2.0

2.30

2.36

mmol/l

39.97

1524

6446

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2929

21068

7.85

206.84

11.3

4.2

17.58

14.70

pmol/l

307.65

2851

19296

(3002256) Pathology report gross observation

654

2102

3.67

169.93

1.4

1.1

—

(40768804) Tissue Pathology biopsy report

1611

8990

2.65

151.84

2.4

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

1320

6784

2.64

145.86

2.3

2.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1771

10568

2.57

141.80

2.6

2.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1794

10928

2.52

135.00

2.8

2.3

78.66

78.19

nmol/l

0.32

1692

9754

(3012095) Magnesium [Moles/volume] in Serum or Plasma

783

3193

2.94

134.07

3.6

2.6

0.82

0.83

mmol/l

1.18

749

2942

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

28.65

120.57

3.3

1.0

22.79

13.25

u/ml

1.86

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

386

1085

3.92

119.79

4.5

1.5

27.83

2.60

ug/l

1.23

297

797

(3024561) Albumin [Mass/volume] in Serum or Plasma

1586

9597

2.33

114.48

5.1

3.8

36.41

36.23

g/l

0.72

1504

8787

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

227

460

5.25

106.48

2.5

2.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

862

4170

2.48

101.40

3.6

2.1

2.40

2.44

mmol/l

13.72

785

3550

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2961

24685

5.27

101.04

14.7

4.9

1.74

2.07

mu/l

1.08

2856

22786

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

486

1792

3.03

97.21

7.4

2.8

1.21

1.23

mmol/l

13.92

454

1484

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2455

18665

2.50

94.50

9.4

5.4

75.66

74.78

u/l

0.65

2372

17302

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

975

5166

2.29

91.78

2.2

2.0

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1710

11409

2.11

88.26

7.0

3.7

10.84

10.92

umol/l

0.09

1640

10640

(40768795) Lymph node Pathology biopsy report

17.54

81.78

1.2

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1898

13400

2.07

81.26

9.4

6.7

3.88

4.12

e9/l

5.25

1662

11584

(3010838) Calcium [Moles/time] in 24 hour Urine

205

481

4.49

80.34

2.4

2.0

5.87

5.26

mmol/24h

1.22

194

413

(3003458) Phosphate [Moles/volume] in Serum or Plasma

578

2727

2.38

68.90

5.3

5.2

1.08

1.04

mmol/l

2.84

536

2512

(3013826) Glucose [Moles/volume] in Serum or Plasma

1876

13975

1.86

59.69

5.0

4.1

6.52

6.62

mmol/l

1.38

1786

12905

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

200

606

3.46

54.49

2.3

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

910

5613

1.88

51.15

3.7

3.3

94.76

92.55

2.16

894

5431

(40768793) Breast Pathology biopsy report

100

192

5.35

49.58

1.3

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

200

721

2.90

40.53

2.0

1.9

5.09

4.52

iu/l

0.31

269

(3022217) INR in Platelet poor plasma by Coagulation assay

1401

10317

1.65

39.58

12.3

14.3

1.17

1.24

inr

2.81

453

3086

(3044889) 12 lead EKG panel

2138

17839

1.64

33.91

4.1

3.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

132

424

3.21

32.66

3.1

2.1

578.76

26.48

u/ml

0.97

113

337

(3019550) Sodium [Moles/volume] in Serum or Plasma

2904

26631

2.39

32.52

18.1

13.0

139.83

139.78

mmol/l

0.51

2866

25903

(3003694) ABO and Rh group [Type] in Blood

917

6334

1.64

31.63

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2907

26727

2.37

31.36

18.5

13.1

3.92

3.95

mmol/l

1.55

2856

25947

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2830

25787

2.10

30.54

17.0

11.3

20.00

20.79

mg/l

0.69

2351

19648

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

364

1942

1.99

30.09

5.4

3.0

233.40

231.97

u/l

0.08

345

1810

(3002030) Lymphocytes/100 leukocytes in Blood

1498

11740

1.53

29.17

6.3

5.9

27.67

28.77

3.53

1411

10951

(3003396) Base excess in Arterial blood by calculation

399

2219

1.92

29.16

7.3

7.4

1.20

1.31

mmol/l

0.24

321

1737

(3019198) Lymphocytes [#/volume] in Blood

1585

12585

1.53

28.97

6.0

5.7

1.91

e9/l

0.02

1411

11157

(3019069) Monocytes/100 leukocytes in Blood

1462

11415

1.53

28.86

6.5

6.1

8.46

8.36

0.59

1374

10614

(40760892) CBC W Ordered Manual Differential panel - Blood

1455

11359

1.53

28.67

6.7

6.0

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

400

2239

1.90

28.63

7.3

5.14

5.08

kpa

0.81

380

2132

(3027801) Oxygen [Partial pressure] in Arterial blood

400

2239

1.90

28.63

7.3

12.62

11.90

kpa

1.95

380

2130

(3006504) Eosinophils/100 leukocytes in Blood

1452

11333

1.53

28.62

6.2

5.8

2.79

2.94

1.64

1365

10516

(3012565) Volume of 24 hour Urine

5.59

28.49

2.9

2.0

1838.75

1888.96

0.13

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

224

1012

2.31

28.39

8.7

10.8

—

(40758558) Short blood count panel - Blood

823

5679

1.61

27.87

7.1

4.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

395

2221

1.89

27.85

3.3

2.9

—

(3016502) Oxygen saturation in Arterial blood

362

1978

1.94

27.83

7.5

7.9

95.75

95.37

0.42

350

1899

(3001604) Monocytes [#/volume] in Blood

1538

12216

1.51

27.51

6.0

5.6

0.57

0.56

e9/l

0.10

1331

10588

(3022096) Basophils/100 leukocytes in Blood

1401

10944

1.51

26.94

6.3

5.9

0.68

0.70

0.69

1312

10113

(3006315) Basophils [#/volume] in Blood

1537

12250

1.50

26.75

6.0

5.6

0.04

e9/l

1.08

1329

10604

(3013115) Eosinophils [#/volume] in Blood

1584

12718

1.50

26.50

6.1

5.8

0.19

0.20

e9/l

0.40

1401

11208

(3002173) Hemoglobin [Mass/volume] in Arterial blood

334

1811

1.95

26.20

7.9

8.2

124.16

122.62

g/l

0.66

326

1756

(3002385) Erythrocyte distribution width [Ratio]

2522

22458

1.65

25.70

21.2

13.3

14.53

14.91

3.05

2503

22016

(3018010) Neutrophils/100 leukocytes in Blood

1462

11634

1.48

25.01

6.1

5.7

57.63

56.82

1.91

1374

10833

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

316

1710

1.94

24.90

1.9

2.2

0.23

0.21

g/l

3.86

305

1555

(3047181) Lactate [Moles/volume] in Blood

161

679

2.45

23.81

4.8

7.0

1.29

1.25

mmol/l

0.19

143

589

(3023368) Bacteria identified in Blood by Culture

752

5270

1.56

23.16

4.3

3.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

231

1148

2.09

23.05

2.2

1.5

37.32

22.77

u/ml

1.06

225

1092

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

18.62

23.02

1.2

1.1

—

(3019225) pH of Specimen

391

2363

1.75

21.47

9.1

3.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

380

2287

1.75

21.16

2.6

1.8

385.84

365.56

nmol/l

0.68

357

2073

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

342

2.90

20.50

1.9

1.2

—

(3039000) Anion gap in Blood

115

449

2.62

20.01

5.5

8.8

11.15

11.38

mmol/l

0.26

107

395

(3018572) Chloride [Moles/volume] in Blood

115

450

2.62

19.92

5.5

8.8

105.93

104.90

mmol/l

2.28

107

396

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

19.81

1.2

0.0

—

(40761511) CBC panel - Blood by Automated count

2893

27180

1.94

19.41

17.2

10.9

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

101

375

2.75

19.40

1.9

1.2

0.11

0.38

nmol/l

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2661

24434

1.62

19.31

16.7

10.1

83.51

81.81

ml/min/173m2

4.08

2337

19646

(3021589) Normoblasts [#/volume] in Blood

1343

10915

1.41

18.45

11.1

7.9

0.00

e9/l

0.56

1120

8914

(3013707) Erythrocyte sedimentation rate by Westergren method

2193

19431

1.44

18.06

4.4

4.1

11.88

11.32

mm/h

1.07

2042

18011

(3008152) Bicarbonate [Moles/volume] in Arterial blood

231

1268

1.89

17.32

6.1

7.3

24.93

24.60

mmol/l

0.80

220

1199

(3018095) Leukocytes [#/volume] in Urine

1034

8179

1.40

16.02

3.6

3.4

63.62

106.44

e6/l

1.33

732

5539

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

334

2.65

15.72

1.8

1.2

—

nmol/l

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

131

606

2.21

15.71

2.4

3.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

204

1110

1.90

15.71

7.8

7.3

25.27

24.78

mmol/l

1.16

199

1105

(3042936) Bacteria identified in Isolate by Culture

443

2988

1.56

15.53

2.0

—

(3019060) Gas panel - Arterial blood

232

1326

1.81

15.28

4.5

5.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1887

16507

1.36

15.23

4.6

4.2

1914.39

1968.44

e6/l

0.01

204

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

428

2918

1.54

14.24

2.8

2.6

21.85

23.28

1.25

346

2465

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

315

2001

1.64

14.15

1.2

137.61

145.27

iu/ml

0.13

122

784

(3035637) Corticotropin [Mass/volume] in Plasma

221

2.94

14.13

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

863

6734

1.39

14.13

3.2

2.9

48.26

65.95

e6/l

0.52

661

5056

(36304419) Bacteria [Presence] in Urine

792

6096

1.40

14.05

3.0

2.8

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

162

854

1.95

13.73

4.7

5.7

1.69

1.63

0.42

154

793

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

334

2.53

13.67

1.3

1.5

—

(3000991) Gas panel - Venous blood

263

1609

1.69

13.64

9.1

7.8

—

(40768800) Prostate Pathology biopsy report

4.95

13.57

1.1

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

159

847

1.92

13.07

4.6

5.8

0.94

0.89

1.08

151

789

(3002032) Base excess in Venous blood by calculation

301

1933

1.62

12.92

3.4

2.08

2.00

mmol/l

0.17

253

1657

(3021447) Carbon dioxide [Partial pressure] in Venous blood

298

1938

1.59

12.13

3.4

5.87

5.86

kpa

0.11

289

1881

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

984

7993

1.34

12.09

3.7

2.7

28.38

33.57

u/l

1.68

936

7567

(3030467) Casts [#/volume] in Urine by Automated count

789

6213

1.36

11.85

3.1

2.8

0.37

e6/l

0.03

603

4652

(3004789) Transferrin [Mass/volume] in Serum or Plasma

448

3199

1.47

11.80

2.7

2.4

2.37

2.39

g/l

0.26

415

2959

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

199

2.85

11.80

1.1

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

458

3285

1.46

11.79

2.9

2.0

30.02

29.67

0.49

447

3162

(3026782) Osmolality of Urine

588

4419

1.41

11.72

2.6

2.7

528.25

527.68

mosm/kgh2o

0.02

505

3735

(3022948) Iron [Moles/volume] in Serum or Plasma

485

3526

1.44

11.62

2.7

2.4

12.75

13.68

umol/l

2.07

454

3270

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

342

2323

1.53

11.48

1.9

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

232

2.66

11.32

1.2

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

463

3354

1.45

11.28

2.1

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1325

11313

1.30

11.12

3.2

2.8

107.60

100.45

ug/l

0.68

1222

10503

(3045142) Bone marrow Pathology biopsy report

132

3.21

10.95

1.1

1.2

—

(3022145) Colonoscopy Study observation

372

2601

1.49

10.86

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

278

1829

1.57

10.75

4.0

1.43

0.62

3.51

440

(3011985) Renin [Units/volume] in Plasma

330

2.34

10.69

1.9

1.4

40.32

50.31

mu/l

0.37

295

(3000850) Epithelial cells [#/volume] in Urine

616

4734

1.38

10.64

2.6

2.4

4.74

6.46

e6/l

3.32

543

4207

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

184

2.80

10.49

1.2

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

753

5983

1.34

10.47

2.4

2.2

3.01

2.85

mg/l

0.94

649

5108

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

170

993

1.75

10.44

10.6

9.2

24.57

24.46

mmol/l

0.20

163

970

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

337

2331

1.50

10.36

1.9

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

926

7593

1.31

10.30

2.6

2.3

59.02

57.90

u/l

0.12

854

6944

(40760888) Immunoglobulin light chains.free panel - Serum

447

2.11

10.24

3.8

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

596

4586

1.37

10.17

3.8

3.6

91.30

436.81

ng/l

7.14

441

3368

(3026008) Bacteria identified in Urine by Culture

926

7605

1.31

10.15

3.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

265

1763

1.55

9.76

4.0

4.1

0.21

0.06

1.41

372

(3014111) Lactate [Moles/volume] in Serum or Plasma

261

1734

1.55

9.67

8.1

6.4

1.26

1.36

mmol/l

1.04

253

1692

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

616

4803

1.35

9.61

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

4.45

9.54

3.1

2.8

—

(3002179) Metamyelocytes/100 leukocytes in Blood

255

1701

1.54

9.28

3.8

1.35

0.48

1.62

397

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.02

9.09

1.4

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

241

2.43

9.04

4.1

3.1

3.10

0.97

1.64

205

(3005719) IgG [Mass/volume] in Serum or Plasma

256

1722

1.53

8.97

3.9

2.4

10.65

10.67

g/l

0.02

235

1575

(3027273) Bicarbonate [Moles/volume] in Venous blood

170

1040

1.67

8.86

3.1

2.9

26.08

25.41

mmol/l

1.58

163

1003

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

110

600

1.86

8.52

3.9

1.4

1.09

1.43

ratio

—

(3037756) Immunofixation for Serum or Plasma

364

2.12

8.51

2.2

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

113

623

1.84

8.46

4.1

1.5

42.00

39.35

mg/l

0.27

502

(3025159) Blasts/100 leukocytes in Blood

251

1703

1.52

8.45

3.9

4.1

0.18

0.05

1.15

323

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

351

2544

1.43

8.44

2.2

7.79

6.78

umol/l

0.33

309

2144

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

434

2.01

8.38

3.5

3.7

58.30

57.27

0.32

434

(40761536) Microorganisms panel - Urine sediment

288

2015

1.47

8.35

4.1

3.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

112

622

1.83

8.21

4.1

1.5

28.68

30.69

mg/l

0.27

498

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.76

8.11

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

203

1327

1.57

8.10

3.0

2.9

126.91

131.08

g/l

1.77

197

1285

(3013512) EKG study

847

7058

1.28

7.94

3.5

3.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

222

1497

1.52

7.71

1.7

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

365

2712

1.39

7.60

1.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

314

2.13

7.56

1.5

1.3

323.43

343.38

pmol/l

0.26

275

(3042631) Mycobacterium sp identified in Specimen

237

2.30

7.52

3.5

3.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

2983

29040

1.69

7.51

27.1

16.8

40.26

40.37

0.21

2783

27111

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

483

3759

1.34

7.49

2.7

2.4

0.97

1.25

e6/l

1.01

273

2112

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

376

2.02

7.48

1.2

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

114

2.92

7.43

1.5

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

246

1713

1.47

7.31

8.7

7.4

9.41

9.55

mmol/l

0.12

230

1637

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

7.29

1.3

0.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

145

900

1.64

7.20

2.1

2.0

6913.35

4061.36

u/l

0.36

375

(3009261) Glucose [Presence] in Urine by Test strip

1418

12625

1.23

7.15

3.8

3.6

0.00

0.01

estimate

1.32

291

2132

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

442

3421

1.34

7.10

2.8

2.6

4.17

3.49

e6/l

0.41

239

1777

(3037467) Urinalysis macro (dipstick) panel - Urine

1905

17495

1.23

7.06

4.6

4.1

—

(3007461) Platelets [#/volume] in Blood

2983

29074

1.66

7.02

27.0

16.8

258.44

257.24

e9/l

0.49

2940

28298

(3024731) MCV [Entitic volume]

2984

29088

1.66

6.99

26.8

16.8

90.09

90.87

19.74

2965

28636

(3000963) Hemoglobin [Mass/volume] in Blood

2985

29103

1.66

6.95

27.0

16.9

135.21

135.55

g/l

0.73

2966

28649

(3010813) Leukocytes [#/volume] in Blood

2984

29091

1.66

6.95

26.9

16.8

6.51

6.61

e9/l

1.43

2939

28204

(3035941) MCH [Entitic mass]

2984

29091

1.66

6.95

26.7

16.7

29.97

30.24

15.69

2965

28637

(3020630) Protein [Mass/volume] in Serum or Plasma

244

1714

1.46

6.94

3.1

1.5

66.88

67.15

g/l

0.22

225

1531

(3026361) Erythrocytes [#/volume] in Blood

2984

29095

1.65

6.90

26.9

16.8

4.54

4.50

e12/l

3.45

2936

28209

(3041096) Erythrocytes [Presence] in Urine by Automated

799

6712

1.26

6.83

3.3

3.2

—

(3023520) Reticulocytes [#/volume] in Blood

232

1621

1.47

6.79

2.6

2.2

73.14

71.02

e9/l

0.31

174

1213

(3021601) Nitrite [Presence] in Urine by Test strip

1400

12497

1.22

6.74

5.1

4.8

0.00

estimate

0.50

289

2174

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

115

2.80

6.73

1.4

2.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

231

2.23

6.63

3.5

2.0

475.63

22.77

u/ml

0.52

205

(3010421) pH of Blood

523

1.80

6.61

4.7

3.7

7.41

7.42

0.46

477

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

113

673

1.70

6.59

2.4

1.8

15.48

1.76

ug/l

0.54

586

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2869

27768

1.44

6.59

12.5

8.7

24.81

25.18

u/l

0.74

2801

26680

(3017446) Testosterone [Moles/volume] in Serum or Plasma

164

1077

1.55

6.46

2.1

2.2

11.06

13.31

nmol/l

2.56

143

960

(3027945) Reticulocytes/100 erythrocytes in Blood

301

2226

1.39

6.44

2.8

2.2

1.79

1.77

0.06

270

1951

(3001019) Free T4 and TSH panel - Serum or Plasma

221

1553

1.46

6.29

2.3

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

424

1.86

6.20

2.3

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

266

1941

1.41

6.16

3.5

2.9

162.93

174.15

ng/l

0.19

242

1758

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

347

1.95

6.16

5.2

5.5

1170.09

411.38

iu/ml

0.52

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

558

1.74

6.13

1.8

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1845

17017

1.21

6.04

3.2

2.9

42.39

41.45

u/l

0.23

1719

15812

(3028626) Oxygen [Partial pressure] in Capillary blood

415

1.85

5.97

2.7

2.9

8.19

8.12

kpa

0.12

406

(3035350) Ketones [Presence] in Urine by Test strip

1388

12493

1.20

5.83

3.8

3.6

0.00

estimate

1.23

307

2331

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

552

1.72

5.81

2.9

3.8

0.34

0.37

u/ml

0.42

318

(3004588) Protein electrophoresis panel - Serum or Plasma

210

1489

1.44

5.72

3.0

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

247

2.08

5.67

1.1

81.48

55.32

u/l

0.96

221

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

885

7649

1.22

5.64

2.3

2.1

150.97

194.58

u/l

1.36

849

7143

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

404

1.83

5.53

1.5

1.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

117

2.58

5.46

1.5

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

615

5132

1.25

5.44

1.7

1.3

2.27

2.37

g/l

0.65

394

3063

(3012501) Base excess in Blood by calculation

436

1.79

5.42

5.2

3.9

2.34

2.46

mmol/l

0.11

283

(3049717) Cytology report of Urine Cyto stain

604

1.66

5.34

2.6

1.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

498

1.73

5.33

3.2

24.99

24.94

mmol/l

0.05

488

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

411

1.79

5.25

2.4

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

191

1355

1.44

5.21

2.5

1.5

1.43

1.27

g/l

0.35

175

1242

(3021901) Oxygen saturation in Capillary blood

340

1.87

5.18

2.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

183

2.20

5.15

2.0

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

140

2.37

5.06

1.5

1.6

28249.55

91180.63

e6/l

0.72

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1033

9137

1.20

5.05

3.4

46.20

54.03

ng/l

0.22

668

5777

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

329

1.87

5.04

1.7

1.4

0.32

0.40

nmol/l

0.42

278

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

658

5574

1.23

5.03

2.0

1.8

1.12

1.01

mg/l

0.28

502

4160

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1087

9664

1.19

5.01

4.0

3.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

289

1.92

4.92

2.5

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

276

2107

1.34

4.86

2.5

2.2

30.23

37.04

u/l

1.86

238

1783

(3052851) Hemolysis interference index of Serum or Plasma

104

663

1.59

4.75

3.1

3.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

251

1.97

4.73

6.1

7.3

11.72

11.92

mg/l

0.12

233

(1616796) Gas panel - Central venous blood

428

1.72

4.61

4.7

3.4

—

(40767503) Oxygen content in Capillary blood by calculation

406

1.74

4.59

2.6

2.4

15.73

16.46

0.77

205

(3010370) Gastrin [Moles/volume] in Serum or Plasma

4.83

4.49

2.6

1.6

39.92

27.32

pmol/l

0.34

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

154

1082

1.45

4.47

2.1

2.0

35.27

39.67

u/l

2.08

135

956

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

419

1.71

4.40

1.6

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.34

4.32

1.2

2.3

—

(3000060) B lymphocytes [#/volume] in Blood

3.34

4.32

1.4

2.0

110.00

168.52

e6/l

—

(3023199) Leukocytes [#/volume] in Pleural fluid

159

2.15

4.21

1.5

1.6

1678.62

2693.80

e6/l

0.59

120

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

310

2459

1.29

4.17

1.5

1.4

—

(3045788) Cell count panel - Pleural fluid

128

2.28

4.12

1.6

1.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.99

4.12

1.3

2.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

323

1.78

4.09

1.7

1.4

—

(40768806) Pleura Pathology biopsy report

104

2.42

4.05

1.5

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

740

6469

1.19

3.98

3.0

2.9

1068.69

1181.51

ng/l

0.40

629

5460

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

6.44

3.98

5.7

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

131

2.23

3.92

2.2

1.4

—

(40768797) Stomach Pathology biopsy report

424

3518

1.24

3.90

1.3

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

176

1299

1.38

3.90

1.4

1.3

30.45

29.35

iu/l

0.17

154

1143

(3047189) Immunofixation for 24 hour Urine

2.89

3.89

2.5

1.1

—

(3017704) Immunofixation for Urine

113

2.31

3.84

1.5

1.2

—

(3012441) Differential panel - Pleural fluid

133

2.19

3.79

1.6

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

453

3803

1.22

3.73

1.4

1.3

403.37

567.96

titre

1.85

839

(4281824) Cell count and differential, peritoneal fluid

154

2.09

3.72

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.45

3.71

2.1

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.70

3.65

1.4

2.9

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.48

3.63

5.9

5.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

412

1.64

3.62

2.0

1.6

0.78

0.77

g/l

0.02

315

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

240

1.85

3.61

2.0

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

170

2.01

3.59

1.7

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

117

2.23

3.57

1.2

1.3

136.36

157.50

mmol/24h

0.78

117

(3026493) Urate [Moles/volume] in Serum or Plasma

725

6381

1.18

3.56

2.7

2.2

2746.76

4916.13

umol/l

1.11

641

5564

(3032352) Blasts [#/volume] in Cerebral spinal fluid

7.79

3.56

1.9

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

2.40

3.55

2.7

2.6

40.80

48.37

1.28

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

192

1.94

3.53

1.2

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

377

1.66

3.51

1.4

101.81

111.91

u/ml

0.47

(3015736) pH of Urine

1107

10093

1.15

3.40

3.5

3.3

5.93

5.89

0.17

760

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.76

3.38

1.3

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

140

2.08

3.37

1.6

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

663

1.48

3.33

2.3

2.1

10.71

11.27

mg/l

0.31

608

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

159

1189

1.36

3.29

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

102

2.26

3.29

2.1

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

248

1.79

3.28

1.8

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

212

1.85

3.26

3.4

2.0

0.92

1.81

g/24h

1.32

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

260

3213

0.79

3.23

4.4

4.6

32.78

32.67

0.05

174

2200

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

402

1.60

3.22

1.3

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

123

2.12

3.19

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.32

3.17

2.2

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

799

7153

1.16

3.12

1.8

1.6

1.34

1.38

mmol/l

0.76

668

6024

(3009214) Lutropin [Units/volume] in Serum or Plasma

559

1.50

3.08

1.5

1.3

13.86

11.41

u/l

0.71

462

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.81

3.08

1.2

1.5

61.48

104.95

ng/l

1.62

(40765096) Chromosome analysis panel by Banding

3.68

3.08

1.2

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.33

3.07

1.5

76.80

72.00

nmol/24h

0.16

(3017354) Segmented neutrophils/100 leukocytes in Blood

160

1.95

3.04

4.3

2.8

57.35

58.33

0.07

132

(3024354) Oxygen [Partial pressure] in Venous blood

204

1602

1.29

3.03

3.3

2.8

4.92

4.63

kpa

0.92

195

1552

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

300

1.68

3.02

2.3

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

300

1.68

3.02

2.3

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

132

975

1.37

2.98

2.8

2.4

0.66

0.65

0.21

132

968

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

10.01

2.98

9.6

1.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

240

1931

1.26

2.94

3.1

2.2

65.37

68.38

ml/min/173m2

0.60

111

732

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

405

1.57

2.91

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

405

1.57

2.91

1.3

—

(3017732) Neutrophils [#/volume] in Blood

224

1790

1.27

2.91

2.7

3.85

5.05

e9/l

2.63

193

1444

(3023419) Bacteria identified in Sputum by Culture

350

1.61

2.91

3.6

2.7

—

(3020891) Body temperature

114

826

1.39

2.90

4.5

4.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

214

1.79

2.88

1.3

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

312

2592

1.23

2.87

1.7

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

702

1.42

2.85

1.3

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

314

1.63

2.82

1.2

—

37.00

—

(3029937) Albumin [Presence] in Urine by Test strip

741

6642

1.15

2.82

4.3

4.0

0.00

estimate

1.08

280

2167

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

579

1.46

2.82

3.9

2.5

3.49

3.56

g/l

0.18

539

(3024928) Oxygen saturation in Venous blood

441

1.53

2.80

3.2

3.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

686

6125

1.15

2.75

1.3

1.98

1.73

u/ml

0.25

191

1669

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

133

999

1.35

2.73

2.8

2.5

1.06

1.23

1.69

133

988

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

5.01

2.72

6.9

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

172

1344

1.30

2.68

2.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1129

10435

1.13

2.67

2.0

1.9

95.23

97.55

pmol/l

0.79

559

5147

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

471

1.50

2.66

1.3

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

385

3290

1.19

2.66

2.3

109.10

116.52

ug/g

0.26

304

2592

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

147

1.91

2.65

1.5

6.17

7.36

u/l

0.23

124

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

228

1.72

2.63

2.7

2.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

636

5668

1.15

2.61

1.5

21.85

21.13

nmol/l

0.21

565

4803

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

282

1.64

2.61

1.9

1.3

—

(3000012) Reticulocyte production index

229

1.71

2.59

1.9

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

538

4739

1.16

2.58

5.5

3.6

2.18

1.80

ug/l

2.31

484

4256

(3013139) Helicobacter pylori Ag [Presence] in Stool

230

1873

1.25

2.57

1.3

1.2

—

(3019150) Specific gravity of Urine by Refractometry

624

5560

1.15

2.56

4.3

4.0

1.02

kg/l

0.11

116

802

(3026389) Candida sp identified in Specimen by Organism specific culture

370

1.55

2.56

1.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.36

2.55

1.0

1.1

0.70

0.73

umol/24h

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

109

804

1.37

2.53

2.8

1.4

9.91

10.30

g/l

0.37

697

(4062490) Immunoglobulin typing, IgG

270

1.64

2.50

1.8

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

116

1.99

2.45

1.7

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

272

1.63

2.43

1.8

1.4

0.32

0.38

g/l

0.54

192

(3028192) IgG subclass 2 [Mass/volume] in Serum

272

1.63

2.43

1.8

1.4

2.61

2.82

g/l

0.24

192

(40768443) Skin Pathology biopsy report

130

993

1.32

2.42

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

273

1.62

2.40

1.8

1.4

6.87

6.76

g/l

0.07

193

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

235

1.67

2.38

1.9

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.42

2.36

1.1

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.15

2.34

3.4

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.15

2.34

3.4

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

629

1.39

2.31

2.8

2.3

179.03

180.02

0.04

591

(40758292) HTLV I+II Ab panel - Serum

4.62

2.27

2.2

1.3

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

3.89

2.25

1.3

1.0

0.44

0.25

nmol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

572

5112

1.15

2.25

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

114

866

1.33

2.23

2.7

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

474

4183

1.16

2.22

1.9

1.8

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

213

1751

1.23

2.22

1.3

63.11

49.41

au/ml

0.29

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

114

867

1.33

2.21

2.7

1.4

7.33

7.44

g/l

0.28

102

765

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

114

867

1.33

2.21

1.9

1.6

1.52

1.53

g/l

0.02

749

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

114

867

1.33

2.21

2.7

1.4

3.58

3.69

g/l

0.43

101

766

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

121

1.91

2.20

1.7

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

608

5466

1.14

2.19

1.6

452.22

38728504.69

pmol/l

5.26

486

4560

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

679

1.37

2.18

2.6

2.1

95.02

93.46

0.32

647

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

158

1.78

2.17

2.8

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

158

1.78

2.17

2.8

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

158

1.78

2.17

2.8

1.3

—

(3036489) Thrombin time

110

837

1.33

2.14

2.3

1.9

21.41

20.91

0.38

712

(3003338) MCHC [Mass/volume]

2312

22419

1.12

2.11

23.5

14.8

332.14

332.02

g/l

0.29

2302

22266

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

107

814

1.33

2.09

1.6

1.7

0.25

0.23

g/l

1.26

765

(3003327) Ova and parasites identified in Stool by Light microscopy

112

858

1.32

2.08

1.6

1.8

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

5.01

2.07

7.6

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

695

1.35

2.05

1.4

327.83

313.04

ug/g

0.33

378

(40768441) Liver Pathology biopsy report

139

1.81

2.04

1.0

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

109

835

1.32

2.04

1.6

1.7

1.20

1.18

g/l

0.16

101

780

(3006184) Hemoglobin [Mass/volume] in Capillary blood

486

1.41

1.97

2.4

2.2

123.04

131.12

g/l

1.63

348

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

106

816

1.31

1.93

2.8

1.4

2.82

2.93

g/l

0.54

715

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.73

1.93

1.0

1.1

1.50

1.80

umol/24h

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

347

1.48

1.92

1.4

1.2

16.61

21.11

u/l

0.58

293

(1002224) Polysomnography panel

138

1101

1.27

1.91

1.0

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

229

1929

1.20

1.91

2.4

14.74

24.53

au/ml

1.82

143

(3004451) EKG impression Narrative

106

1.89

1.90

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

192

1591

1.22

1.89

1.5

1.4

—

(3035880) pH of Pleural fluid

2.09

1.86

1.3

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

429

3812

1.15

1.85

4.5

3.5

22.18

24.08

1.98

225

1670

(3008757) Leukocyte morphology finding [Identifier] in Blood

175

1.66

1.82

6.8

3.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

443

1.41

1.82

1.4

1.2

290.54

252.24

u/ml

0.51

273

(3022475) Manganese [Moles/volume] in Blood

4.17

1.82

1.2

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.05

1.80

2.0

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.96

1.79

1.1

—

(3011648) Oxygen content in Venous blood

176

1.65

1.79

2.1

2.4

10.89

11.31

0.20

176

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

165

0.42

1.78

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

100

774

1.30

1.77

1.0

1.1

2.01

5.61

u/ml

1.54

(3016018) Differential panel - Cerebral spinal fluid

248

1.54

1.76

1.5

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

849

7879

1.11

1.76

3.2

7.20

7.25

mmol/l

0.13

720

6691

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.09

1.76

1.3

1.1

—

(3003181) Sodium [Moles/volume] in Urine

397

1.42

1.73

1.2

1.3

63.07

63.80

mmol/l

0.04

324

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.85

1.71

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1057

0.76

1.67

1.4

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.19

1.67

1.3

1.1

—

(3000494) Fungus identified in Specimen by Culture

334

2941

1.15

1.65

1.6

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

253

1.51

1.63

1.4

1.2

1.75

2.82

ug/l

2.20

223

(3024891) Influenza virus A+B Ag [Presence] in Specimen

609

1.32

1.62

1.1

1.2

—

(3021788) Differential panel - Synovial fluid

463

1.37

1.61

1.6

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.95

1.59

1.2

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

586

1.32

1.57

1.3

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.85

1.56

1.0

1.2

122.82

110.89

1.02

(3045414) Leukocytes [Presence] in Urine

1155

0.78

1.54

1.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

528

1.33

1.53

1.5

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.34

1.52

1.0

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.34

1.52

7.8

3.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.60

1.51

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.95

1.48

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

139

1.66

1.48

1.4

1.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

403

1.37

1.45

1.3

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.37

1.45

1.7

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

614

0.71

1.44

1.3

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

158

1327

1.20

1.42

4.0

3.4

5.18

5.19

kpa

0.02

151

1257

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

623

1.29

1.41

1.3

1.2

14.91

42.09

u/ml

—

(3009343) pH of Capillary blood

156

1310

1.20

1.41

4.0

3.4

7.41

0.18

146

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

303

2690

1.14

1.37

3.2

2.6

0.74

0.69

ug/l

0.72

216

1686

(3017509) Phencyclidine [Presence] in Urine

2.61

1.36

1.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

2.94

1.36

7.8

3.5

22.60

21.94

mg/l

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

163

0.49

1.35

10.5

17.1

1027.88

1475.28

nmol/l

—

158

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.76

1.34

1.2

1.3

—

(3012516) Albumin [Mass/volume] in Urine

785

7349

1.09

1.33

3.3

3.2

1016.03

307.80

mg/l

1.81

476

4475

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

558

1.30

1.33

1.4

1.3

40.26

33.85

e6/l

0.12

437

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

559

1.29

1.32

1.4

1024.21

1398.59

e6/l

0.20

462

(3003740) Influenza virus B Ag [Presence] in Specimen

394

1.35

1.31

1.2

1.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

217

1.48

1.30

1.7

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

217

1.48

1.30

1.7

1.4

—

(3025941) Bacteria identified in Stool by Culture

171

1461

1.18

1.29

1.2

—

(3037121) Protein [Mass/volume] in Urine

739

1.25

1.29

3.9

2.6

0.17

0.33

g/l

2.34

230

(3002523) Influenza virus A Ag [Presence] in Specimen

395

1.35

1.29

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.36

1.29

1.5

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.36

1.29

1.5

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.36

1.29

1.5

1.0

—

(36660697) Celiac disease serology panel - Serum

253

2230

1.15

1.28

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

107

876

1.23

1.27

1.7

1.6

306.42

300.75

mu/l

0.07

100

783

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.00

1.27

5.8

2.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.05

1.26

1.2

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

159

0.50

1.24

8.3

12.6

562.88

829.80

nmol/l

—

152

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

195

1.49

1.24

2.8

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

382

3464

1.12

1.24

1.7

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

685

0.76

1.22

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

149

1266

1.19

1.22

4.1

3.4

2.67

1.76

mmol/l

2.65

120

943

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.97

1.22

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1106

0.81

1.21

1.4

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

138

1166

1.19

1.20

1.3

2.44

0.91

u/ml

0.32

107

(40768446) Kidney Pathology biopsy report

1.75

1.19

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

222

1.45

1.18

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.31

1.18

1.8

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

204

1785

1.15

1.17

1.3

104.49

200.53

u/ml

3.22

186

1650

(3007566) Smooth muscle Ab [Titer] in Serum

696

1.24

1.16

1.2

80.00

89.06

titre

0.23

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

174

1.50

1.15

2.9

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

725

1.23

1.13

3.1

1.4

0.64

0.39

g/l

0.21

620

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1738

16854

1.07

1.13

3.2

3.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

816

1.22

1.13

1.4

1.3

12.74

52.43

u/ml

—

(3016750) Collection duration of Urine

127

1.58

1.11

1.9

2.2

489.73

500.24

min

0.23

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

217

1.43

1.11

1.4

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.38

1.09

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

409

0.71

1.07

1.7

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.87

1.07

4.8

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.87

1.07

4.8

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.87

1.07

4.8

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

454

0.72

1.06

1.7

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

641

1.24

1.06

2.7

1.4

0.04

0.01

g/l

0.35

587

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

113

1.60

1.05

1.6

1.7

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

121

0.49

1.05

1.8

6.1

—

54.77

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.27

1.03

2.4

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

2.27

1.03

4.8

6.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

221

1.41

1.02

1.2

0.19

1.28

u/ml

1.80

123

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

599

1.24

1.02

2.7

1.4

0.00

g/l

-0.00

547

(3020682) Albumin/Creatinine [Ratio] in Urine

817

7742

1.08

1.02

3.9

3.8

10.74

7.80

mg/mmol

0.69

489

4710

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

196

1.43

1.02

4.3

4.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.92

1.02

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

147

1.50

1.00

1.0

1.1

1.05

u/l

0.01

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.77

1.00

1.1

—

(3044941) Cell count panel - Synovial fluid

413

1.29

1.00

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

592

1.24

1.00

2.7

1.4

0.00

g/l

-0.00

546

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

197

1.43

0.99

1.5

2.2

2.00

2.16

u/field

0.04

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

274

1.35

0.99

1.2

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

132

0.53

0.98

2.3

2.7

46528.57

37980.87

ug/l

—

132

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

292

1.34

0.97

1.8

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.97

0.0

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.85

0.96

3.5

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.00

0.95

0.0

2.4

—

43.56

—

(21494755) Public health laboratory ask at order entry panel

224

2495

0.89

0.94

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

485

4520

1.09

0.93

1.8

1.7

1169.08

1159.88

nmol/l

0.08

388

3428

(3000330) Specific gravity of Urine by Test strip

106

1244

0.85

0.93

3.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

565

0.78

0.91

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

564

0.78

0.90

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

563

0.78

0.89

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

562

0.78

0.88

1.3

1.4

—

(3044007) Cell count panel - Peritoneal fluid

1.91

0.88

1.9

3.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

105

896

1.18

0.88

1.5

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

241

0.66

0.87

1.3

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.86

0.87

1.5

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

186

1.40

0.87

1.2

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.00

0.87

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

163

1441

1.14

0.86

1.1

—

(3024471) HLA-A [Type]

1.72

0.86

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

170

1.41

0.85

1.2

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

112

1.52

0.84

1.9

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.94

0.84

1.5

2.4

1.33

0.81

u/field

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.59

0.84

1.2

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.78

0.84

1.3

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

112

0.53

0.83

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

171

1.41

0.83

1.3

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

232

1.34

0.81

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

172

1.40

0.80

1.2

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2583

26136

0.93

0.80

4.4

1.47

1.52

mmol/l

5.98

2408

24279

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

392

1.25

0.79

1.1

1.0

2.01

2.85

u/ml

0.47

182

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.00

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

286

1.30

0.78

1.8

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1083

0.85

0.78

2.1

1.7

3.61

4.12

mg/l

0.24

795

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.77

0.0

1.1

—

30.43

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.00

0.77

0.0

1.0

—

0.22

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2490

25220

0.94

0.77

3.9

1.30

1.28

mmol/l

0.57

2304

23224

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

287

1.29

0.77

1.8

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.76

0.0

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

687

1.18

0.76

2.8

1.4

38.64

37.93

g/l

0.54

586

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

272

2957

0.91

0.76

1.6

1.7

1.38

1.43

0.73

235

2624

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.70

0.75

1.4

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

413

1.24

0.75

1.4

1.2

2.18

3.40

u/ml

0.64

131

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

315

1.27

0.75

1.9

1.6

65.76

59.26

0.49

195

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.09

0.74

5.0

9.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

351

1.26

0.74

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

405

1.24

0.74

1.3

1.2

5.17

5.56

u/ml

0.06

168

(3044290) Cell count panel - Cerebral spinal fluid

505

1.21

0.74

1.4

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

451

1.22

0.73

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.64

0.73

1.0

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

150

1.40

0.73

1.6

1.5

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.00

0.72

1.2

3.4

—

15.49

—

(3051593) INR in Capillary blood by Coagulation assay

108

0.55

0.72

1.2

9.0

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.58

0.71

1.0

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2449

24173

1.06

0.70

5.8

5.6

39.26

39.45

mmol/mol

0.49

2289

22474

(3043238) Trisomy 21 risk [Likelihood] in Fetus

487

0.80

0.69

1.4

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

520

0.81

0.69

1.4

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

195

1.34

0.69

2.6

2.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

624

5944

1.06

0.68

3.9

3.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

475

0.80

0.68

1.3

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.85

0.68

4.2

1.9

—

(37021550) Renin [Units/volume] in Plasma --upright

1.64

0.68

1.4

1.3

102.50

56.22

mu/l

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

751

1.16

0.68

1.4

1.3

3.59

5.55

u/ml

0.56

126

(3011288) Drugs identified in Urine by Screen method

573

0.82

0.67

1.9

2.8

—

(3044927) Protein electrophoresis panel - Urine

249

1.29

0.67

1.2

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

0.54

0.67

4.0

2.6

34.40

28.76

umol/l

—

(3005033) Fetal Nuchal fold Thickness US

472

0.80

0.65

1.3

1.4

—

(3033799) Differential panel - Peritoneal fluid

1.59

0.65

3.1

2.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.59

0.65

1.1

1.3

—

(3024932) HLA-DR beta [Type]

1.61

0.65

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

172

1.34

0.63

1.9

2.4

—

(4146454) Self-monitoring of blood glucose

269

0.74

0.63

2.3

2.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

381

0.79

0.63

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.67

0.61

1.4

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2605

26300

0.94

0.61

4.5

4.4

4.71

4.77

mmol/l

2.69

2448

24566

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

390

0.79

0.61

1.4

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

741

1.15

0.60

1.4

1.3

1.80

6.66

u/ml

0.63

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

2.17

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

0.03

—

(3014051) Protein [Presence] in Urine by Test strip

671

0.85

0.59

2.1

2.4

—

(3022621) pH of Urine by Test strip

183

1676

1.10

0.58

3.1

2.8

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

300

1.24

0.58

1.2

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

106

1.42

0.57

3.9

1.7

190.60

190.89

u/l

0.01

106

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

161

0.68

0.57

1.2

1.4

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

283

1.24

0.56

2.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

150

1648

0.91

0.56

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.46

0.56

1.0

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2595

25706

1.06

0.55

4.7

4.5

5.91

5.87

mmol/l

0.78

2411

23591

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.62

0.55

3.2

2.3

—

(3024869) Neuronal Ab [Presence] in Serum

1.58

0.54

1.0

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

1.58

0.54

1.5

1.9

13.71

11.19

g/l

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.47

0.54

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

285

1.23

0.54

1.2

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

404

1.19

0.54

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

825

1.13

0.53

1.7

1.5

0.42

0.13

iu/ml

0.33

160

(3036180) Methadone [Presence] in Urine

1.43

0.53

2.4

1.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

490

1.17

0.51

1.3

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

197

1.27

0.51

1.2

1.1

29.18

34.15

mg/l

0.43

165

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

678

1.14

0.50

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

141

1287

1.10

0.50

1.5

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

716

1.13

0.50

1.3

—

(21494434) Karyotype in Bone marrow

145

1.31

0.48

1.1

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2654

26743

0.95

0.48

5.0

4.9

2.80

2.82

mmol/l

0.69

2476

24857

(40765089) Chromosome analysis panel - Blood by G-banded

1.52

0.48

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

163

1.29

0.48

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

175

1619

1.09

0.47

1.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.49

0.47

2.1

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

102

1.37

0.47

1.0

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.41

0.46

2.0

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.41

0.46

2.0

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

210

0.76

0.46

1.4

8.63

8.38

mmol/l

0.08

204

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

120

0.67

0.45

1.1

—

(3042733) HLA Ab [Presence] in Serum

1.45

0.44

4.7

5.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.37

0.44

1.0

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

764

1.12

0.42

1.2

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

415

1.16

0.42

3.1

3.2

0.84

0.83

nmol/l

0.09

316

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

812

1.11

0.42

1.4

1.3

239.88

216.41

miu/ml

0.24

406

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.64

0.42

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.56

0.42

1.0

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

130

1196

1.09

0.42

1.7

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

140

1.29

0.42

1.3

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

858

0.89

0.41

5.1

3.6

25.69

24.86

mmol/l

1.47

788

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

323

1.18

0.41

1.2

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

213

1.22

0.40

5.3

3.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.15

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

114

1.32

0.40

3.4

2.2

22.03

88.62

ug/l

0.48

103

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

114

1.32

0.40

1.3

1.1

—

(3000492) Spirometry study

265

2509

1.06

0.40

1.5

1.4

—

(3015183) Erythrocyte sedimentation rate

132

1.29

0.40

1.3

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

216

0.79

0.40

1.4

1.1

—

(3023410) Appearance of Cerebral spinal fluid

241

1.21

0.40

1.6

1.4

—

(3026480) Teichoate Ab [Titer] in Serum

0.00

0.40

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.40

0.0

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

2.6

—

3.65

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

149

0.74

0.40

1.1

1.0

0.31

0.49

u/ml

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

278

1.19

0.40

1.9

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

399

1.16

0.40

1.1

0.62

1.83

u/ml

1.11

198

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

231

2446

0.94

0.39

1.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.43

0.39

4.8

4.7

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

0.08

—

(3019977) pH of Arterial blood

106

1.32

0.39

1.6

2.8

7.41

7.43

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

279

1.18

0.38

1.9

1.4

—

(4200892) Spirometry reversibility

177

1889

0.93

0.38

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

866

1.10

0.38

2.7

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

114

1049

1.09

0.38

1.7

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.32

0.37

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

772

1.10

0.37

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

281

1.18

0.36

1.9

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

129

1389

0.93

0.36

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

621

1.11

0.36

1.7

1.6

17860.38

10771.16

e6/l

0.58

452

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

100

918

1.09

0.36

1.8

1.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.43

0.35

1.2

3.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

236

1.19

0.34

1.9

1.4

33.73

33.59

0.01

145

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

263

2759

0.95

0.34

1.9

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

307

0.85

0.33

1.3

2.0

3.45

5.17

umol/l

1.39

212

(3006442) Creatine [Moles/volume] in Serum or Plasma

182

1.21

0.33

1.5

1.6

79.23

78.19

umol/l

0.06

182

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.70

0.33

1.0

1.4

7.24

8.57

ug/l

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

294

1.16

0.32

1.7

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

379

1.14

0.32

1.6

1.4

30.77

28.37

u/l

0.15

290

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

137

1.24

0.32

1.3

1.2

—

(40761535) Cells panel - Urine sediment

195

2056

0.94

0.31

3.8

3.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

572

1.10

0.30

2.6

2.3

159.48

101.53

ug/min

0.36

347

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

278

1.15

0.29

1.5

1.8

—

1417.14

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

130

0.77

0.29

1.1

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

746

1.09

0.29

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

227

0.84

0.28

1.3

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

227

0.84

0.28

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

227

0.84

0.28

1.3

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.30

0.28

1.8

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.30

0.28

1.8

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.29

0.28

1.4

3.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.29

0.28

1.4

3.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

758

1.08

0.27

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

226

0.84

0.27

1.3

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

479

0.90

0.26

1.7

1.3

—

(3022313) Gas panel - Capillary blood

104

973

1.07

0.26

4.3

3.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

225

0.84

0.26

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

225

0.84

0.26

1.3

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

376

1.12

0.26

2.7

2.6

13.45

13.19

0.59

371

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

291

1.14

0.26

1.7

2.3

38.90

24.66

mg/l

—

(3028433) Virus identified in Specimen by Culture

1.23

0.25

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

1.22

0.25

1.2

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

801

1.08

0.25

2.2

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

349

1.12

0.25

1.5

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

435

1.11

0.25

2.0

1.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

308

0.88

0.24

1.4

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

329

0.88

0.24

1.1

0.56

4.19

u/ml

—

129

(3028707) Methadone [Presence] in Urine by Screen method

371

0.89

0.24

2.1

2.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

134

1.20

0.22

1.3

1.4

159.49

227.85

pmol/l

0.46

134

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

153

1.18

0.22

1.0

1.1

—

(3048879) Bone marrow aspiration report

1.22

0.22

1.2

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

401

1.10

0.21

1.1

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

8.79

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

7.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

398

0.90

0.21

1.1

50.00

1556.13

iu/ml

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

154

1.17

0.21

1.0

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

209

0.86

0.21

1.2

1.4

1.39

1.42

nmol/l

0.04

189

(3017315) Amylase [Enzymatic activity/volume] in Urine

126

1.19

0.21

1.0

1.2

176.27

327.36

u/l

0.90

112

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

2.33

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

4.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

249

1.13

0.20

2.2

2.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

249

1.13

0.20

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

117

1112

1.05

0.20

1.3

1.4

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.20

0.0

1.4

—

2.68

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

24.44

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.20

0.0

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.12

—

(3051651) Icteric interference index of Serum or Plasma

108

1.20

0.20

7.4

4.3

—

(3034426) Prothrombin time (PT)

1.21

0.19

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

394

1.09

0.19

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

302

0.89

0.19

1.0

1.1

0.18

0.25

u/ml

—

(3024263) Appearance of Synovial fluid

133

0.83

0.19

1.5

1.4

—

(3008898) HLA-B27 [Presence]

103

978

1.05

0.19

1.1

—

(3004775) Volume in Urine collected for unspecified duration

184

1.14

0.19

2.1

2.4

644.20

612.98

0.10

128

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.13

0.18

1.0

1.1

136.85

42.97

u/ml

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

386

1.09

0.18

1.1

124.00

118.32

0.48

348

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

216

0.88

0.17

1.7

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.11

0.17

1.0

1.3

—

(4034850) Laboratory test

915

1.05

0.16

12.5

9.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

437

1.08

0.16

1.1

4.09

4.83

u/ml

0.23

224

(3028679) Herpes simplex virus Ab [Presence] in Serum

120

1.17

0.16

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.11

0.16

1.3

2.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

370

0.92

0.16

1.0

1.1

1.49

2.57

u/ml

0.74

174

(3032773) Endomysium IgG Ab [Titer] in Serum

216

1.11

0.15

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

487

1.07

0.15

2.0

2.1

0.88

0.80

nmol/l

0.48

401

(3045683) HLA typing for celiac disease panel - Blood or Tissue

178

1.12

0.15

1.1

1.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

595

1.06

0.15

1.3

1.2

13.57

3.55

u/ml

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

311

3041

1.03

0.15

1.6

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

103

1.17

0.13

1.3

1.9

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

335

1.08

0.13

1.6

1.9

—

4.00

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

161

1.12

0.13

1.3

1.1

1.08

1.04

ratio

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

355

1.07

0.12

1.3

51.90

42.51

u/ml

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

238

2433

0.98

0.12

1.7

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

133

1.13

0.12

1.5

1.4

6.93

7.51

ug/l

0.14

110

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

114

1.14

0.11

1.7

2.0

—

(3017569) Oxygen content in Arterial blood

1.16

0.11

1.5

1.9

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

115

0.87

0.10

1.2

1.1

1950.30

1610.07

miu/ml

—

115

(3051387) C reactive protein [Mass/volume] in Capillary blood

546

0.95

0.10

2.8

3.5

34.23

24.66

mg/l

0.57

338

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

203

1987

1.02

0.10

2.0

2.3

7.62

7.02

ug/l

0.11

175

1736

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

712

1.04

0.10

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.14

0.10

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.14

0.10

1.0

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

497

5028

0.99

0.09

1.3

39.01

32.28

iu/ml

0.32

162

1586

(3051101) Glucose [Moles/volume] in Cord blood

1.04

0.09

6.0

7.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

185

0.92

0.08

1.5

1.3

1.59

g/l

0.01

185

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.78

0.08

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

1.08

0.08

1.4

1.5

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.81

0.07

1.2

1.4

16.32

16.95

umol/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

184

0.92

0.07

1.0

35.14

49.98

ng/l

0.58

119

(3000034) Microalbumin [Mass/volume] in Urine

245

0.94

0.07

4.3

2.9

49.18

22.47

mg/l

0.53

171

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

153

0.91

0.07

1.3

1.4

—

597.33

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

501

1.04

0.07

1.0

1.1

1.43

2.68

u/ml

0.99

261

(3036071) Salmonella sp Ab [Titer] in Serum

0.82

0.07

1.0

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

489

4846

1.01

0.07

1.3

14.90

11.96

u/ml

0.34

182

1932

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.89

0.06

1.1

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

650

0.97

0.06

1.7

2.0

—

(1761868) Lipid panel - Serum or Plasma

949

9542

0.99

0.06

2.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

103

0.87

0.06

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

323

3196

1.01

0.06

7.7

6.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

129

1.09

0.05

1.1

1.0

0.09

0.28

u/ml

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

188

1.06

0.05

1.4

1.6

0.75

1.27

promille

0.87

146

(3023511) Choriogonadotropin [Units/volume] in Urine

506

0.97

0.05

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

425

1.04

0.05

1.0

1.1

0.76

0.88

u/ml

0.09

180

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

171

0.94

0.05

1.0

1.1

5.44

11.35

iu/ml

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

181

0.94

0.05

1.0

875.09

721.46

ng/l

0.42

114

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

221

0.95

0.04

1.4

1.00

0.96

g/l

0.38

221

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

180

0.94

0.04

1.0

283.73

357.73

ng/l

0.53

119

(44813793) Dust mix specific IgE antibody measurement

190

0.95

0.04

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

129

0.93

0.03

1.1

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

732

0.98

0.03

1.0

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

122

1.07

0.02

1.0

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

132

1.06

0.02

1.1

1.4

124.43

137.39

nmol/l

1.36

132

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

152

1.05

0.02

1.1

1.2

—

(3016879) Cocaine [Presence] in Urine

761

0.99

0.02

1.6

2.1

—

(3025130) Human papilloma virus identified in Specimen

399

0.98

0.02

1.5

1.7

—

(3028300) Cannabinoids [Presence] in Urine

830

0.99

0.02

1.6

2.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

581

1.02

0.02

3.6

4.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

153

1.05

0.01

1.0

1.20

0.84

u/ml

—

(3019832) Treponema pallidum Ab [Presence] in Serum

217

2180

1.00

0.01

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

407

0.98

0.01

1.1

—

(3027944) Amphetamines [Presence] in Urine

813

1.01

0.01

1.6

2.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

154

1.04

0.00

1.1

1.2

—

(3027008) Opiates [Presence] in Urine

826

0.99

0.00

1.6

2.0

—

(3014271) Vancomycin [Susceptibility]

111

0.99

0.00

2.6

2.9

—

(3006270) Folate [Moles/volume] in Blood

235

1.02

0.00

1.2

357.53

385.75

nmol/l

0.27

211

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

169

1.01

0.00

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

144

0.97

0.00

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

404

0.99

0.00

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

102

0.98

0.00

1.8

2.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

102

0.98

0.00

1.3

1.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

122

0.98

0.00

1.3

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

822

1.00

0.00

1.6

2.0

—

(3009871) Measles virus Ab [Titer] in Serum

1.03

0.00

1.9

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

133

0.98

0.00

1.6

1.4

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1228.00

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

2.2

—

4.53

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.0

1.3

—

217.83

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

5.8

—

0.24

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3022689) Creatine [Moles/volume] in Urine

0.92

-0.00

1.4

1.5

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3020650) Glucose [Presence] in Urine

0.95

-0.00

1.3

1.7

—

(3006462) Nitrate [Presence] in Urine

120

1.00

-0.00

2.1

3.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.92

-0.00

1.3

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

0.96

-0.00

1.8

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

690.46

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.02

-0.00

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.95

-0.00

1.2

1.5

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.89

-0.00

1.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

-0.00

0.0

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_THYROID_GLAND_WIDE – Malignant neoplasm of thyroid gland, including Hilmo

GWS hits: 18

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of thyroid gland, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of thyroid gland, including Hilmo (C3_THYROID_GLAND_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints